The ABPI Board is pleased to announce that Kate Brunner QC has been appointed Chair of the PMCPA Appeal Board.
The government has announced a new £20 million Medicines and Diagnostic Manufacturing Transformation Fund to expand medicines manufacturing and improve medicine supply chains.
The Chancellor has unveiled the government's spending plans for the coming year, including for NHS funding, clinical research, and cutting-edge R&D.
Following the fourth meeting of the Ireland/Northern Ireland Specialised Committee, the UK and the EU have agreed a phased process for implementing medicines regulation in Northern Ireland up to 31 December 2021.
The growing importance of Northern Ireland’s pharmaceutical and life sciences industries is revealed in a new report tracking the significant contribution the sector makes to the NI economy.
The Prime Minister has said that the UK must prepare for 'no deal' but has indicated that negotiations between the EU and UK on the post-Brexit relationship will continue.
The UK is set to join two initiatives bringing together some of the world’s leading regulators to allow pharmaceutical companies to submit medicines to be reviewed by several countries at the same time.
The Department for Transport has announced details of Government-secured freight routes for the end of the Brexit transition period.
The ABPI and Northern Ireland’s Medicines Optimisation Innovation Centre have announced a new partnership to deliver ‘triple win’ benefits to patients, NI HSC and the economy.
The UK has been leading the rest of Europe in early-stage clinical research according to new data published by the ABPI in its second annual report on the state of clinical trials in the UK.
The Chief Executive of the UK’s pharmaceutical industry association has today warned MPs about the consequences of not agreeing a comprehensive post-Brexit trade deal or an urgent agreement on medicines while the trade talks continue.